Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04965493 |
|---|---|
| Brief Title: | A Trial of Pirtobrutinib (LOXO-305) Plus Venetoclax and Rituximab (PVR) Versus Venetoclax and Rituximab (VR) in Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (BRUIN CLL-322) |
| First Submitted : | July 15, 2021 |
| First Submitted that Met QC Criteria : | July 15, 2021 |
| First Posted : | July 16, 2021 |
| Last Update Submitted that Met QC Criteria : | May 10, 2024 |
| Last Update Posted : | May 13, 2024 (Estimate) |